| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/2014 | US20140288017 Catechol diethers as potent anti-hiv agents |
| 09/25/2014 | US20140288016 Method of providing an anti-ulcer treatment with extracts and isolated flavonoids from euphorbia cuneata |
| 09/25/2014 | US20140288015 Methods and devices for affecting nerve function |
| 09/25/2014 | US20140288014 Compositions of crude algal oil |
| 09/25/2014 | US20140288013 Methods and compositions for the management of cancer using 2-dg and an igf-ir inhibitor |
| 09/25/2014 | US20140288010 Compositions and Methods for Increasing Stem Cell Survival |
| 09/25/2014 | US20140287997 Use of growth hormone or growth hormone receptor agonists to prevent or treat stress-sensitive psychiatric illness |
| 09/25/2014 | US20140287993 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/25/2014 | US20140287991 Hepatitis B Virus-Binding Polypeptides and Methods of Use Thereof |
| 09/25/2014 | US20140287988 Macrogol 15 hydroxystearate formulations |
| 09/25/2014 | US20140287983 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis |
| 09/25/2014 | US20140287076 Fatty acid composition and plant extract and pharmaceutical preparation and application thereof |
| 09/25/2014 | US20140287075 Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals |
| 09/25/2014 | US20140287074 Extracts of deschampsia antartica with antineoplastic activity |
| 09/25/2014 | US20140287071 Veterinary supplements |
| 09/25/2014 | US20140287067 Anti-tumoural effects of cannabinoid combinations |
| 09/25/2014 | US20140287064 Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument |
| 09/25/2014 | US20140287059 Method of treating a bacteria-induced gastric disorder |
| 09/25/2014 | US20140287058 Composition for maintaining bone health and for treating osteoarthritis and osteoarthrosis of the joints |
| 09/25/2014 | US20140287057 Dietary product intended for the prevention of cardiometabolic risk |
| 09/25/2014 | US20140287054 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
| 09/25/2014 | US20140287053 Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |
| 09/25/2014 | US20140287052 Treatment of adrenal insufficiency |
| 09/25/2014 | US20140287051 Orally administered corticosteroid compositions |
| 09/25/2014 | US20140287050 Amino acid conjugates of quetiapine, process for making and using the same |
| 09/25/2014 | US20140287049 Nanoparticle-based drug delivery |
| 09/25/2014 | US20140287048 Paste comprising non-steroidal anti-inflammatory drug |
| 09/25/2014 | US20140287047 Nanoemulsion therapeutic compositions and methods of using the same |
| 09/25/2014 | US20140287044 Fibrin sealant (fibringluraas) consisting of a kit of lyophilized or frozen high concentrate fribinogen |
| 09/25/2014 | US20140287042 Oral Tablet Formulation Consisting Of Fixed Combination Of Rosuvastatin And Ezetimibe For Treatment Of Hyperlipidemia And Cardiovascular Diseases |
| 09/25/2014 | US20140287041 Methylphenidate Extended Release Chewable Tablet |
| 09/25/2014 | US20140287040 Formulation |
| 09/25/2014 | US20140287038 Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product |
| 09/25/2014 | US20140287037 Extended-release topiramate capsules |
| 09/25/2014 | US20140287036 Soft-gelatin capsule formulation |
| 09/25/2014 | US20140287030 Antileishmanial compositions and methods of use |
| 09/25/2014 | US20140287028 Use of Chemotherapeutic Agents |
| 09/25/2014 | US20140287027 Vesicle-encapsulated corticosteroids for the treatment of cancer |
| 09/25/2014 | US20140287024 Nanoparticle-based delivery system with oxidized phospholipids as targeting ligands for the prevention, diagnosis and treatment of atherosclerosis |
| 09/25/2014 | US20140287021 Treatment of chemotherapy-induced peripheral neuropathy |
| 09/25/2014 | US20140287004 Use of an Omega-3 Lipid-Based Emulsion Following Ischemic Injury to Provide Protection and Recovery in Human Organs |
| 09/25/2014 | US20140287003 Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| 09/25/2014 | US20140286984 Compositions and Methods for the Treatment or Prevention of Hepatitis B Virus Infection |
| 09/25/2014 | US20140286969 Anti-egfr antibody drug conjugate formulations |
| 09/25/2014 | US20140286962 Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disorders |
| 09/25/2014 | US20140286961 Novel Methods Of Cancer Therapy Targeted Against A Cancer Stem Line |
| 09/25/2014 | US20140286949 Method of attenuating reactions to skin irritants |
| 09/25/2014 | US20140286945 Enzyme inhibitor for cancer treatment |
| 09/25/2014 | US20140286943 Cyclopropyl modulators of p2y12 receptor |
| 09/25/2014 | US20140286938 Spiroketals |
| 09/25/2014 | US20140286931 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |
| 09/25/2014 | US20140286928 Treatment of heart disease by inhibition of the action of ribosomal s6 kinase 3 (rsk3) |
| 09/25/2014 | US20140286923 Nutritional supplement for weight management |
| 09/25/2014 | US20140286913 Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| 09/25/2014 | US20140286909 Composition for use in increasing insulin sensitivity and/or reducing insulin resistance |
| 09/25/2014 | US20140286908 Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery |
| 09/25/2014 | US20140286903 Substituted Purine Nucleosides, Phosphoramidate and Phosphordiamidate Derivatives for Treatment if Viral Infections |
| 09/25/2014 | US20140286902 Combination therapy of hsp90 inhibitors with platinum-containing agents |
| 09/25/2014 | US20140286901 Methods, Pharmaceutical Compositions and Kits for Use in the Treatment of Adult T-Cell Leukemia/Lymphoma |
| 09/25/2014 | US20140286900 2'-branched nucleosides and flaviviridae mutation |
| 09/25/2014 | US20140286899 Inhibitors of hepatitis c virus |
| 09/25/2014 | US20140286897 Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein |
| 09/25/2014 | US20140286894 Compositions comprising crosslinked cation-binding polymers and calcium and/or magnesium cations, and uses thereof |
| 09/25/2014 | US20140286891 Ion binding polymers and uses thereof |
| 09/25/2014 | US20140286884 Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications |
| 09/25/2014 | US20140286883 Delivery system having stabilized ascorbic acid and other actives |
| 09/25/2014 | US20140286879 Combinations of medicaments for the treatment of respiratory diseases |
| 09/25/2014 | US20140286878 Composition for inhalation |
| 09/25/2014 | US20140286877 Compositions comprising salbutamol sulphate |
| 09/25/2014 | US20140286876 Veterinary active agent application |
| 09/25/2014 | US20140286873 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 09/25/2014 | US20140286872 Nanoparticle for targeting brain tumors and delivery of o6-benzylguanine |
| 09/25/2014 | US20140286867 Use of tnfalpha inhibitor for treatment of erosive polyarthritis |
| 09/25/2014 | US20140284245 Pharmaceutical compositions of dimethyl fumarate |
| 09/25/2014 | DE10246329B4 Duftstoffrezeptoren Perfume receptors |
| 09/25/2014 | DE102013204110A1 Wirkstoffkombinationen aus Alkylamidothiazolen und einem oder mehreren Cyclodextrinen Active ingredient combinations of one or more cyclodextrins and Alkylamidothiazolen |
| 09/24/2014 | EP2781600A1 Method for producing myo-inositol and myo-inositol derivative |
| 09/24/2014 | EP2781599A1 Nucleic acid fragment binding to target protein |
| 09/24/2014 | EP2781598A1 Nucleic acid molecule for inhibiting activity of rnai molecule |
| 09/24/2014 | EP2781525A2 Novel derivatives of hemin with antibacterial and antiviral activity |
| 09/24/2014 | EP2781523A1 Lipophilic oligonucleotide analogs |
| 09/24/2014 | EP2781521A1 Novel spiroindoline compound, and medicinal agent comprising same |
| 09/24/2014 | EP2781520A1 Three-ring pi3k and/or mtor inhibitor |
| 09/24/2014 | EP2781519A1 Novel antiviral pyrrolopyridine derivative and a production method for same |
| 09/24/2014 | EP2781518A2 Fluorine-containing 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1h-pyrido[4,3-b]indoles as agents for reducing uncontrolled protein aggregation |
| 09/24/2014 | EP2781517A1 Nitrogenated heterocyclic compound |
| 09/24/2014 | EP2781516A2 New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid |
| 09/24/2014 | EP2781513A1 Benzofuran derivatives |
| 09/24/2014 | EP2781512A1 Oxadiazole compound and preparation method thereof, pharmaceutical composition and use thereof |
| 09/24/2014 | EP2781510A1 HIV inhibiting 5,6-substituted pyrimidines |
| 09/24/2014 | EP2781508A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists |
| 09/24/2014 | EP2781505A1 Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates |
| 09/24/2014 | EP2781225A1 Intestinal fibrosis treatment agent |
| 09/24/2014 | EP2781219A1 Use of sedoheptulose for prevention or treatment of inflammation |
| 09/24/2014 | EP2781218A1 Use of sedoheptulose as a nutritional supplement |
| 09/24/2014 | EP2781217A1 ROR gamma modulators |
| 09/24/2014 | EP2781216A1 Chemokine receptor activity regulator |
| 09/24/2014 | EP2781214A1 Formulation of amorphous calcium L-5-methyltetrahydrofolate (L-5-MTHF-Ca) |
| 09/24/2014 | EP2781212A1 Long-acting formulations of insulins |
| 09/24/2014 | EP2780456A1 Therapeutic rna switches compositions and methods of use |